By considering MM molecular subtype, we highlight differences in evolution trajectories, particularly between HRD and IG translocated MM, but also between t(4;14) and t(11;14) and/or between CCND2 and CCND1 driven tumors [5]. The gene discussed is CCND2; the disease is Miyoshi myopathy.